Perioperative Hemodynamic Control - β-Adrenergic Antagonists (Table 20.3)
To view the entire topic, please log in or purchase a subscription.
Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drugs, procedures, and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and PRIME Journals. Explore these free sample topics:
-- The first section of this topic is shown below --
Propranolol
Propranolol is a nonselective β1- and β2-adrenergic receptor antagonist available in both IV and oral forms. Propranolol is highly lipophilic; it is almost entirely absorbed following oral administration and undergoes up to 75% first-pass clearance by the liver. Hemodynamic effects of propranolol and other β-adrenergic antagonists are secondary to the reduction of cardiac output and suppression of the renin–angiotensin system. β-Adrenergic antagonists can be distinguished by their relative β1 selectivity, their intrinsic sympathomimetic activity, and their pharmacologic half-lives.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Propranolol
Propranolol is a nonselective β1- and β2-adrenergic receptor antagonist available in both IV and oral forms. Propranolol is highly lipophilic; it is almost entirely absorbed following oral administration and undergoes up to 75% first-pass clearance by the liver. Hemodynamic effects of propranolol and other β-adrenergic antagonists are secondary to the reduction of cardiac output and suppression of the renin–angiotensin system. β-Adrenergic antagonists can be distinguished by their relative β1 selectivity, their intrinsic sympathomimetic activity, and their pharmacologic half-lives.
There's more to see -- the rest of this topic is available only to subscribers.